Skip to main content

Terry Gou to pay for genetic test research for breast cancer, leukemia
facebook line twitter Print

node name:
Taipei, May 13 (CNA) Taiwanese tycoon Terry Gou announced on Saturday that the healthcare foundation he created will fund genetic test clinical research into breast cancer and leukemia, providing free tests for everyone who participates in the program for the next 10 years.

Two months ago, Gou announced the formation of an anti-cancer alliance between his Yonglin Healthcare Foundation with National Taiwan University Cancer Center, China-based BGI and U.S-based Nantworks and HudsonAlpha, as well as the biotech sector in Taiwan.

After two months of preparation, Gou announced the foundation will pay for clinical research into genetic tests for breast cancer and leukemia in the hope of benefiting more patients.

Gou, founder and chairman of Hon Hai Precision Industry Co., the world's largest contract electronics maker, said that the two cancers have been the "bane of his life."

Gou's first wife died from breast cancer in 2005, while his younger brother Tony Gou died from leukemia in 2007.

He said that he intends to pool the world's top talent, combining high tech and top-notch medicine to fight the scourge of cancer.

His dream is to make cancer a chronic disease and ultimately a rare disease, Gou said, adding that the foundation will work closely with frontline medical teams.

"I'm confident it represents a ray of hope in the battle against cancer," Gou said.